What Photon Fusion Ltd does

Photon Fusion Ltd is a London-based biotech scientific and strategic advisory practice founded and operated by Dr. Michal Legiewicz. The firm operates as a sole-practitioner boutique consultancy serving platform biotechnology companies in the Pre-seed through Series B funding window. Its core thesis is that the most consequential failures in platform biotech arise at the interfaces between technical design, IP architecture, and commercial positioning — domains typically addressed in silos by separate advisers. The firm positions itself as the integrated reader across these three domains, combining bench-level scientific fluency, practitioner-level patent experience (Dr. Legiewicz is a named inventor on nucleic acid constructs), and commercial strategy advisory built over more than twenty years across NIH, Yale, the University of Warwick, and UK biotech (Touchlight Genetics).

The firm's services are organized into three engagement tiers: (1) Fractional Strategic Leadership, where the Principal Advisor holds an embedded CTO or CSO role at approximately 20% of working time with continuous strategic presence; (2) Focused Project Engagements with scope defined in a Statement of Work and producing written deliverables such as IP landscape reviews, platform technical assessments, competitive intelligence synthesis, or fundraising/licensing preparation; and (3) Advisory & Due Diligence, comprising one-off sessions, expert calls, due diligence reviews, and scientific advisory board participation with a minimum half-day booking. The firm has developed proprietary decision intelligence frameworks, most notably the Synthetic Terrain Mapping Circuit (STMC) — a fusion of the Cynefin sensemaking framework, military Battle Damage Assessment, Intelligence Preparation of the Battlefield, and reoriented Wardley mapping — alongside a Three-Lens Analysis Framework and a Cross-Domain Risk Mapping methodology. An interactive STMC visualization is publicly accessible on the firm's website.

The business model is professional services consulting with custom pricing across all tiers, no publicly disclosed fees, and a selective engagement philosophy that prioritizes mandates where the integrated perspective can have decisive impact. Distribution is direct-to-client with no intermediary or reseller channels. Marketing relies on thought leadership content via a Substack publication, LinkedIn professional presence, and the firm's website (photonfusion.io). The company is registered as a private limited company in England & Wales (Company No. 17087137) at Suite Ra01, 195-197 Wood Street, London E17 3NU. No external investment, partnerships beyond historical academic affiliations, named customers, or revenue figures are disclosed in available sources.

Name

Photon Fusion Ltd

Legal name

Photon Fusion Ltd

Website

https://photonfusion.io

Company type

Private

Founded year

2026

Operating status

Operating

Headcount range

1–10 employees

Short description

Photon Fusion Ltd is a London-based biotech advisory practice led by Dr. Michal Legiewicz, providing integrated scientific, IP, and commercial strategic counsel to platform biotech founders and leaders from Pre-seed through Series B.

Ownership category

akta.pro rank

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Fractional Strategic Leadership: Deep embedded advisory engagement where the Principal Advisor holds a defined fractional role (typically CTO or CSO) within client leadership, operating at approximately 20% working time. This is an ongoing engagement model with continuous strategic presence.
2. Focused Project Engagement: Bounded engagements with specific objectives and written deliverables such as IP landscape review, platform technical assessment, competitive intelligence synthesis, or fundraising/licensing preparation. Scope defined in Statement of Work before commencement.
3. Advisory & Due Diligence Sessions: Discrete one-off advisory sessions, expert calls, due diligence reviews, or advisory board participation. Minimum booking of half a day. No fixed term or operational involvement.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Photon Fusion is a boutique biotech advisory practice that provides scientific, IP, and commercial strategy consulting to early-stage platform biotechnology companies, founders, CSOs, and investors. The firm delivers engagements across three tiers — embedded Fractional Strategic Leadership (CTO/CSO at ~20% time), Focused Project Engagements (IP landscape reviews, platform technical assessments, competitive intelligence), and discrete Advisory & Due Diligence sessions — supported by proprietary decision intelligence frameworks such as the Synthetic Terrain Mapping Circuit (STMC).

Product overview

Photon Fusion Ltd is a scientific and strategic advisory practice for platform biotechnology, not a software product company. The firm offers three tiers of consulting engagement: Technical Services (Scientific & Technology Input on vector design and synthesis workflows), Strategic Services (IP & Platform Strategy with cross-domain dependency mapping), and Advisory Services (Founder & Investor Advisory at inflection points). Engagement models range from Fractional Strategic Leadership (embedded CTO/CSO role at ~20% time) to Focused Project Engagements (defined scope with written deliverables) to Discrete Advisory & Due Diligence sessions. The firm also develops proprietary decision intelligence frameworks including the Synthetic Terrain Mapping Circuit (STMC) that integrates Cynefin, military Battle Damage Assessment, and Wardley mapping. Services are delivered exclusively through direct consulting engagements with founder Dr. Michal Legiewicz, with no software product, API, or standalone platform.

Differentiator

Problem solved

Functional benefit

Products and services

• Fractional Strategic Leadership (CTO/CSO — embedded advisory)
• Focused Project Engagement
• Advisory & Due Diligence Sessions
• Synthetic Terrain Mapping Circuit (STMC)

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Five partnerships are on record, tiered minor.

• UCL (University College London)minorStrategic or Co-development Partner · 1 January 2024Dr. Legiewicz co-supervised a PhD programme at UCL on aptamer-ended closed linear DNA for nuclear import in non-dividing cells (completed 2024). The research originated from an idea by Dr. Legiewicz and was conducted alongside the lead advisor at UCL. Represents academic collaboration on nucleic acid therapeutics research.
• NIH (National Institutes of Health)minorStrategic or Co-development PartnerPast affiliation: Dr. Legiewicz conducted bench research at NIH as part of his career following the interfaces between technical, legal, and commercial decisions in nucleic acid science. This represents historical employment rather than active partnership.
• Yale UniversityminorStrategic or Co-development PartnerPast affiliation: Dr. Legiewicz conducted bench research at Yale University. Historical research affiliation rather than active partnership.
• University of WarwickminorStrategic or Co-development PartnerPast affiliation: Platform development experience at University of Warwick as part of career spanning nucleic acid science and biotech platform development. Historical affiliation.
• Touchlight GeneticsminorStrategic or Co-development PartnerPast affiliation: UK Biotech experience at Touchlight Genetics in platform development. Historical employment rather than active partnership.

Scale indicators3 records

Expansion highlights4 records

Direct peers

• Health Advances: Strategy consultancy focused on biotech, medtech, and diagnostics companies, helping clients with corporate strategy, market opportunity assessment, and transaction support — closely aligned with Photon Fusion's integrated scientific-commercial advisory role for early-stage platforms.
• Alacrita Consulting: Boutique life sciences consulting firm offering strategic, commercial, and technical advisory to biotech and pharma clients, including due diligence and platform assessments — directly comparable in firm size, client segment, and depth of technical involvement.
• Back Bay Life Science Advisors: Life sciences-focused investment banking and advisory firm serving emerging biotech companies on financing, licensing, and strategic transactions — directly comparable as a senior advisory boutique serving early-to-mid-stage biotech platforms.
• Catenion: Berlin-based boutique strategy consultancy specializing in biotech and pharmaceutical innovation strategy, with proprietary frameworks for evaluating pipeline and platform value — comparable in boutique scale, biotech focus, and methodology-led positioning.
• Defined Health: Boutique strategic advisory firm serving biotech and pharmaceutical companies on pipeline strategy, platform positioning, and commercial assessment — directly comparable as a senior-led advisory practice serving the same founder/CEO/CSO buyer at the Pre-seed through commercial stage.

Broad incumbents

• Simon-Kucher & Partners: Global consulting firm specializing in pricing, market access, and growth strategy with a substantial life sciences practice — broadly comparable incumbent in the biotech advisory space, though its emphasis is on commercial/monetization rather than integrated science-IP-commercial positioning.
• L.E.K. Consulting: Global management consulting firm with a substantial life sciences practice serving pharma, biotech, and medtech clients on commercial strategy and transaction support — operates in the same biotech advisory space but at significantly larger scale and broader portfolio.
• ZS Associates: Global consulting firm with deep pharma and biotech practice focused on commercial strategy, launch, and analytics — broader incumbent serving similar biotech clients but at much greater scale and with data/analytics emphasis rather than founder-led integrated advisory.
• McKinsey & Company (Biopharma practice): Global management consulting firm with a large biopharma practice covering strategy, R&D, and commercial topics — broadly comparable as an incumbent that competes for biotech strategic advisory mandates, though its scale and generalist model differ from Photon Fusion's boutique positioning.
• Trinity Life Sciences: Life sciences commercial strategy and insights firm serving biotech and pharma clients across the product lifecycle — broader incumbent with overlapping biotech advisory work, though more commercial-focused and less integrated with scientific/IP reading than Photon Fusion.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/in/michalsky

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Photon Fusion Ltd